A Louvain-la-Neuve
17 crédits
Horaire adapté - En anglais
Sigle du programme: MEDE2FC
Mémoire/Travail de fin d'études : OUI
Stage : NON
Activités en anglais: OUI
Activités en d'autres langues : NON
Activités sur d'autres sites : NON

Introduction

CARAQA_VisuVideo2.jpg      Picto_Registration.png

 

THIRD EDITION OF THE CERTIFICATE, UPCOMING – JANUARY 2022 – MAY 2022 (approximate schedule)

The last infosession took place on the 4th of November. Slides are available here.
Please contact caraqa@uclouvain.be if you want more information.



The Louvain School of Engineering of UCLouvain and Medidee jointly organise a new University Certificate in “CARAQA.be : Clinical, regulatory and quality affairs for medical devices and in-vitro diagnosis”.

This continuing education programme will consist of four modules organized from November 2021 to April 2022. Classes will be held in Louvain-la-Neuve and will consist of more than 170 hours of training.


Highlights of the programme
  • New European regulation requiring experts in the field

  • Critical know-how to boost innovation management in MedDev and IVD companies

  • Crucial demand of start-ups, medium and large companies for this expertise

  • Limited training offer in Benelux

  • Covers the requirements of MDR / IVDR Article 15 “ Person responsible for regulatory compliance

This programme has been designed in accordance with the “CARAQA” international training network, including academia from Belgium, Switzerland, Germany and Denmark. For more information, go to https://caraqa.com


Votre profil

  • Biomedical, mechanical, electronic, software or material science engineers, in charge of medical or IVD development projects

  • Physicians, scientists or inventors of biomedical devices

  • Employees within the regulatory, clinical and/ or quality department of a manufacturing or subcontracting company manufacturing medical devices or IVD, or in a healthcare organization

  • Specialists involved in the design of sensitive medical products


In collaboration with :